Home » Stocks » AzurRx BioPharma

AzurRx BioPharma, Inc. (AZRX)

Stock Price: $1.13 USD 0.10 (9.71%)
Updated Aug 12, 2020 4:00 PM EDT - Market closed
After-hours: $1.00 -0.13 (-11.50%) Aug 12, 7:59 PM

Stock Price Chart

Key Info

Market Cap 32.21M
Revenue (ttm) n/a
Net Income (ttm) -15.78M
Shares Out 28.50M
EPS (ttm) -0.64
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 12, 2020
Last Price $1.13
Previous Close $1.03
Change ($) 0.10
Change (%) 9.71%
Day's Open 1.08
Day's Range 0.91 - 1.30
Day's Volume 5,250,968
52-Week Range 0.37 - 1.94

More Stats

Market Cap 32.21M
Enterprise Value 33.80M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 28.50M
Float 26.51M
EPS (basic) -0.64
EPS (diluted) -0.64
FCF / Share -0.47
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 121,075
Short Ratio 0.15
Short % of Float 0.13%
Beta 2.03
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 10.22
Revenue n/a
Operating Income -13.07M
Net Income -15.78M
Free Cash Flow -12.71M
Net Cash -1.60M
Net Cash / Share -0.06
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -95.30%
ROE -548.38%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (2)

Buy 2
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$1.97*
(74.34% upside)
Low
0.90
Current: $1.13
High
3.00
Target: 1.97
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year201920182017201620152014
Revenue------
Operating Income-14.74-13.22-10.08-6.63-4.73-2.33
Net Income-15.18-13.53-11.10-14.59-5.93-2.37
Shares Outstanding22.4315.4410.636.503.633.54
Earnings Per Share-0.68-0.88-1.04-2.24-1.63-0.67
Operating Cash Flow-14.03-10.87-7.18-4.53-4.17-1.01
Capital Expenditures-0.02-0.06-0.03-0.01-0.02-0.19
Free Cash Flow-14.06-10.92-7.22-4.55-4.19-1.20
Cash & Equivalents0.221.160.601.810.660.24
Total Debt1.520.260.420.166.581.05
Net Cash / Debt-1.300.900.191.65-5.91-0.81
Assets8.907.475.486.756.696.58
Liabilities4.293.003.823.5410.323.93
Book Value4.624.471.663.21-3.632.64
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name AzurRx BioPharma, Inc.
Country United States
Employees 10
CEO James E. Sapirstein

Stock Information

Ticker Symbol AZRX
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: AZRX
IPO Date October 11, 2016

Description

AzurRx BioPharma, Inc., a clinical stage biopharmaceutical company, focuses on the development of recombinant proteins for the treatment of gastrointestinal diseases. The company's therapeutic products are administered to patients as oral non-systemic biologics. Its lead therapeutic is MS1819, a recombinant lipase for the treatment of exocrine pancreatic insufficiency for cystic fibrosis and chronic pancreatitis patients. The company was incorporated in 2014 and is headquartered in Brooklyn, New York.